An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers

BACKGROUND: The reason for the poor prognosis of estrogen receptor (ER) + /human epidermal growth factor receptor 2 (HER2)− breast cancer patients with high levels of tumor-infiltrating lymphocytes (TILs) is poorly understood. The association between TILs and response to neoadjuvant endocrine therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Reiko, Watanabe, Takahiro, Morimoto, Koji, Fujimoto, Yukie, Nagahashi, Masayuki, Ishikawa, Eri, Hirota, Seiichi, Miyoshi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404203/
https://www.ncbi.nlm.nih.gov/pubmed/37115435
http://dx.doi.org/10.1007/s12282-023-01462-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404203/
https://www.ncbi.nlm.nih.gov/pubmed/37115435
http://dx.doi.org/10.1007/s12282-023-01462-5

Ejemplares similares